Back to Search Start Over

Quantitative assessment of painful diabetic peripheral neuropathy after high-frequency spinal cord stimulation: a pilot study.

Authors :
Kissoon NR
LeMahieu AM
Stoltenberg AD
Bendel MA
Lamer TJ
Watson JC
Sletten DM
Singer W
Source :
Pain medicine (Malden, Mass.) [Pain Med] 2023 Oct 13; Vol. 24 (Supplement_2), pp. S41-S47.
Publication Year :
2023

Abstract

Objective: Randomized trials have demonstrated efficacy of spinal cord stimulation (SCS) for treatment of painful diabetic neuropathy (PDN). Preliminary data suggested that treatment of PDN with high-frequency SCS resulted in improvements on neurological examination. The purpose of the present study was to explore whether patients with PDN treated with high-frequency SCS would have improvements in lower-extremity peripheral nerve function.<br />Design: Prospective cohort study in an outpatient clinical practice at a tertiary care center.<br />Methods: Patients with PDN were treated with high-frequency SCS and followed up for 12 months after SCS implantation with clinical outcomes assessments of pain intensity, neuropathic symptoms, and neurological function. Small-fiber sudomotor function was assessed with the quantitative sudomotor axon reflex test (QSART), and large-fiber function was assessed with nerve conduction studies (NCS). Lower-extremity perfusion was assessed with laser Doppler flowmetry.<br />Results: Nine patients completed 12-month follow-up visits and were observed to have improvements in lower-extremity pain, weakness, and positive sensory symptoms. Neuropathy impairment scores were improved, and 2 patients had recovery of sensory responses on NCS. A reduction in sweat volume on QSART was observed in the proximal leg but not at other sites. No significant differences were noted in lower-extremity perfusion or NCS as compared with baseline.<br />Conclusions: The improvement in pain relief was concordant with improvement in neuropathy symptoms. The findings from this study provide encouraging preliminary data in support of the hypothesis of a positive effect of SCS on peripheral neuropathy, but the findings are based on small numbers and require further evaluation.<br />Trial Registration: ClinicalTrials.gov ID NCT03769675.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1526-4637
Volume :
24
Issue :
Supplement_2
Database :
MEDLINE
Journal :
Pain medicine (Malden, Mass.)
Publication Type :
Academic Journal
Accession number :
37833046
Full Text :
https://doi.org/10.1093/pm/pnad087